Inflammation in COPD: Pathogenesis, local and systemic effects

Romanian Journal of Morphology and Embryology

Volumn 52, Issue 1, 2011, Pages 21-27

  Barbu, Cornelia ^a   Iordache, Mihaela ^a   Man, M G ^a  

^a Endocrinology Department   (Romania)

Author keywords

COPD; Local inflammation; Systemic inflammation; Systemic manifestations

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; INFLAMMATION; PATHOLOGY;

HUMANS; INFLAMMATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 79953050101     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Reilly JJ, Silverman EK, Shapiro SD, Chronic obstructive pulmonary disease. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL (eds), Harrison's principles of internal medicine, 16th edition, McGraw-Hill Professional, 2004, 1547-1560.
2. MacNee W, ZuWallack RL, Keenan J, Clinical management of chronic obstructive pulmonary disease, 2nd edition, Professional Communications, New York, 2005.
3. Jeffery PK, Pathology of asthma compared with chronic obstructive pulmonary disease. In: Adkinson F, Busse WW, Bochner BS, Holgate ST, Simons FER, Lemanske RF (eds), Middleton's allergy: principles and practice, 7th edition, Mosby, 2009, 921-936.
4. Bathoorn E, Kerstjens H, Postma D, Timens W, MacNee W, Airways inflammation and treatment during acute exacerbations of COPD, Int J Chron Obstruct Pulmon Dis, 2008, 3(2):217-229.
5. Barnes PJ, Shapiro SD, Pauwels RA, Chronic obstructive pulmonary disease: molecular and cellular mechanisms, Eur Respir J, 2003, 22(4):672-688.
6. White AJ, Gompertz S, Bayley DL, Hill SL, O'Brien C, Unsal I, Stockley RA, Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis, Thorax, 2003, 58(8):680-685.
7. Wetzler LM, The role of Toll-like receptor 2 in microbial disease and immunity, Vaccine, 2003, 21(Suppl 2):S55-S60.
8. Ritter M, Mennerich D, Weith A, Seither P, Characterization of Toll-like receptors in primary lung epithelial cells: strong impact of the TLR3 ligand poly(I:C) on regulation of Toll-like receptors, adaptor proteins and inflammatory response, J Inflamm (Lond), 2005, 2:16.
9. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL, Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations, Am J Respir Crit Care Med, 2006, 173(10):1114-1121.
10. Kitaguchi Y, Fujimoto K, Kubo K, Honda T, Characteristics of COPD phenotypes classified according to the findings of HRCT, Respir Med, 2006, 100(10):1742-1752.
11. Brightling CE, Monteiro W, Ward R, Parker D, Morgan MD, Wardlaw AJ, Pavord ID, Sputum eosinophilia and shortterm response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial, Lancet, 2000, 356(9240):1480-1485.
12. Barnes PJ, Chronic obstructive pulmonary disease, N Engl J Med, 2000, 343(4):269-280.
13. Hewson CA, Jardine A, Edwards MR, Laza-Stanca V, Johnston SL, Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells, J Virol, 2005, 79(19):12273-12279.
14. Zagai U, Sköld CM, Trulson A, Venge P, Lundahl J, The effect of eosinophils on collagen gel contraction and implications for tissue remodeling, Clin Exp Immunol, 2004, 135(3):427-433.
15. Hogan RJ, Usherwood WJ, Zhong W, Roberts AA, Dutton RW, Harmsen AG, Woodland DL, Activated antigenspecific CD8+ T-cells persist in the lung following recovery from respiratory virus infection, J Immunol, 2001, 166(3):1813-1822.
16. Majori M, Corradi M, Caminati A, Cacciani G, Bertacco S, Pesci A, Predominant TH1 cytokine pattern in peripheral blood from subjects with chronic obstructive pulmonary disease, J Allergy Clin Immunol, 1999, 103(3 Pt 1):458-462.
17. Majo J, Ghezzo H, Cossio MG, Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema, Eur Respir J, 2001, 17(5):946-953.
18. Agustí A, MacNee W, Donaldson K, Cosio M, Hypothesis: does COPD have an autoimmune component?, Thorax, 2003, 58(10):832-834.
19. Willemse BWM, ten Hacken NHT, Rutgers B, Postma DS, Timens W, Association of current smoking with airway inflammation in chronic obstructive pulmonary disease and asymptomatic smokers, Respir Res, 2005, 6:38.
20. Willemse BWM, ten Hacken NHT, Rutgers B, Lesman- Leegte IG, Postma DS, Timens W, Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers, Eur Respir J, 2005, 26(5):835-845.
21. Wouters EFM, Groenewegen KH, Dentener MA, Vernooy JHJ, Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations, Proc Am Thorac Soc, 2007, 4(8):626-634.
22. Wouters EF, Local and systemic inflammation in chronic obstructive pulmonary disease, Proc Am Thorac Soc, 2005, 2(1):26-33.
23. Agustí A, Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should), Proc Am Thorac Soc, 2007, 4(7):522-525.
24. Vernooy JH, Küçükaycan M, Jacobs JA, Chavannes NH, Buurman WA, Dentener MA, Wouters EF, Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum, Am J Respir Crit Care Med, 2002, 166(9):1218-1224.
25. Hurst MR, Wilkinson TM, Perera WR, Donaldson GC, Wedzicha JA, Relationships among bacteria, upper airway, lower airway, and systemic inflammation in COPD, Chest, 2005, 127(4):1219-1226.
26. Vassilakopoulos T, Roussos C, Zakynthinos S, The immune response to resistive breathing, Eur Respir J, 2004, 24(6):1033-1043.
27. Rabinovich RA, Figueras M, Ardite E, Carbó N, Troosters T, Filella X, Barberà JA, Fernandez-Checa JC, Argilés JM, Roca J, Increased tumour necrosis factor-alpha plasma levels during moderate-intensity exercise in COPD patients, Eur Respir J, 2003, 21(5):789-794.
28. van Eeden SF, Hogg JC, The response of human bone marrow to chronic cigarette smoking, Eur Respir J, 2000, 15(5):915-921.
29. van Eeden SF, Yeung A, Quinlam K, Hogg JC, Systemic response to ambient particulate matter: relevance to chronic obstructive pulmonary disease, Proc Am Thorac Soc, 2005, 2(1):61-67.
30. Gan WQ, Man SF, Senthilselvan A, Sin DD, Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a metaanalysis, Thorax, 2004, 59(7):574-580.
31. Hurst JR, Donaldson GC, Perera WR, Wilkinson TM, Bilello JA, Hagan GW, Vessey RS, Wedzicha JA, Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 2006, 174(8):867-874.
32. Perera WR, Hurst JR, Wilkinson TM, Sapsford RJ, Müllerova H, Donaldson GC, Wedzicha JA, Inflammatory changes, recovery and recurrence at COPD exacerbation, Eur Respir J, 2007, 29(3):527-534.
33. Pepys MB, Hirschfield GM, C-reactive protein: a critical update, J Clin Invest, 2003, 111(12):1805-1812.
34. Marc MM, Korosec P, Kosnik M, Kern I, Flezar M, Suskovic S, Sorli J, Complement factors c3a, c4a and c5a in chronic obstructive pulmonary disease and asthma, Am J Respir Cell Mol Biol, 2004, 31(2):216-219.
35. Pinto-Plata VM, Livnat G, Girish M, Cabral H, Masdin P, Linacre P, Dew R, Kenney L, Celli BR, Systematic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD, Chest, 2007, 131(1):37-43.
36. Creutzberg EC, Wouters EF, Vanderhoven-Augustin IM, Dentener MA, Schols AM, Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 2000, 162(4 Pt 1):1239-1245.
37. Masaki T, Chiba S, Tatsukawa H, Yasuda T, Noguchi H, Seike M, Yoshimatsu H, Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice, Hepatology, 2004, 40(1):177-184.
38. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H, Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes, Biochem Biophys Res Commun, 2004, 323(2):630-635.
39. Wang CH, Li SH, Weisel RD, Fedak PW, Dumont AS, Szmitko P, Li RK, Mickle DA, Verma S, C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle, Circulation, 2003, 107(13):1783-1790.
40. Beltowski J, Leptin and atherosclerosis, Atherosclerosis, 2006, 189(1):47-60.
41. Wedzicha JA, Syndercombe-Court D, Tan KC, Increased platelet aggregate formation in patients with chronic airflow obstruction and hypoxaemia, Thorax, 1991, 46(7):504-507.
42. Ferroni P, Basili S, Martini F, Vieri M, Labbadia G, Cordova C, Alessandri C, Gazzaniga PP, Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease, J Investig Med, 2000, 48(1):21-27.
43. Esmon CT, The interaction between inflammation and coagulation, Br J Haematol, 2005, 131(4):417-430.